Contracts Management Branch, NICHD, National Institutes of Health, Executive Building, Suite 7A07, 6100 Executive Blvd MSC 7510, Bethesda, Maryland 20892-7510

A -- DEVELOPMENTAL STUDIES HYBRIDOMA BANK SOL SS-NICHD-CRMC-96-01 POC Contact Mr. Charles Newman, 301-496-4611/Contract Specialist The National Institute of Child Health and Human Development (NICHD) has a continuing requirement for a Developmental Studies Hybridoma Bank (DSHB). The DSHB will continue to obtain store and distribute hybridomas and/or antibodies for research on developmental biology during a three year phase out period of the project in which the NICHD will provide progressively small amounts of funding. The DSHB will also perform all of the bookkeeping, order-taking, advertising, and interactions with the scientific community. The NICHD has supported the Developmental Studies Hybridoma Bank (DSHB) for the past ten years with two consecutive five year contracts to the Johns Hopkins University. The contractor has been providing two types of functions: 1) identify, acquire, store, and distribute hybridomas and/or their products (antibodies) that have been demonstrated to be useful to study embryonic development; 2) produce, characterize, and distribute hybridomas/ antibodies that are expected to be useful to study embryonic development. The University of Iowa, subcontractor for Johns Hopkins, has maintained the DSHB on both of the NICHD contracts while Johns Hopkins, the prime contractor, has produced the antibodies to human cluster determinants. The portion of the project performed by the Johns Hopkins University will be completed on October 31, 1996. As a result, the NICHD plans to award a three year contract to phase out support of the DSHB, to the University of Iowa, using other than full and open competition in accordance with 41 U.S.C. 252 C (1) and FAR 6.302-1. At the end of the three year period, the NICHD will provide no further funding for the DSHB. The purpose of this synopsis is to determine whether there are other sources capable of meeting the Government's requirements as described. Capability statements should be submitted within 45 days of publication of this synopsis to Mr. Charles Newman, NIH, NICHD, CMB, Executive Building, Room 7A07, 6100 Executive Boulevard, MSC 7510 Bethesda, Maryland 20892-7510 and should include details specifying how this work would be performed. See numbered note 22. (0207)

Loren Data Corp. http://www.ld.com (SYN# 0006 19960726\A-0006.SOL)